Biogen Inc. (BIIB)

Basic

  • Market Cap

    $34B

  • EV

    $39.42B

  • Shares Out

    144.9M

  • Revenue

    $9,993.3M

  • Employees

    8,725

Margins

  • Gross

    75.12%

  • EBITDA

    25.38%

  • Operating

    20.63%

  • Pre-Tax

    16.1%

  • Net

    14.63%

  • FCF

    10.62%

Returns (5Yr Avg)

  • ROA

    12.28%

  • ROE

    30.39%

  • ROCE

    23.23%

  • ROIC

    20.7%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    $318.34

  • P/E

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

Per Share

  • Rev

    $69.17

  • Earnings (Dil)

    $10.05

  • FCF

    $7.3

  • Book Value

    $99.96

Growth (CAGR)

  • Rev 3Yr

    -11.18%

  • Rev 5Yr

    -5.46%

  • Rev 10Yr

    4.59%

  • Dil EPS 3Yr

    -30.83%

  • Dil EPS 5Yr

    -8.06%

  • Dil EPS 10Yr

    3.51%

  • Rev Fwd 2Yr

    -2.66%

  • EBITDA Fwd 2Yr

    -1.29%

  • EPS Fwd 2Yr

    -6.19%

  • EPS LT Growth Est

    0.47%

Dividends

  • Yield

    —

  • Payout

    —

  • DPS

    —

  • DPS Growth 3Yr

    —

  • DPS Growth 5Yr

    —

  • DPS Growth 10Yr

    —

  • DPS Growth Fwd 2Yr

    —

Select a metric from the list below to chart it

Dec '13
Dec '15
Dec '17
Dec '19
Dec '21
LTM
Metric
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
LTM

Revenues

10,886.8

11,379.8

10,692.2

8,846.9

7,987.8

7,807.7

Other Revenues, Total

2,566.1

2,998.1

2,752.4

2,134.8

2,185.6

2,185.6

Total Revenues

13,452.9

14,377.9

13,444.6

10,981.7

10,173.4

9,993.3

Total Revenues % Chg.

9.6%

6.9%

-6.5%

-18.3%

-7.4%

-3.6%

Cost of Goods Sold, Total

1,816.3

1,955.4

1,805.2

2,109.7

2,278.3

2,486.0

Gross Profit

11,636.6

12,422.5

11,639.4

8,872.0

7,895.1

7,507.3

Selling General & Admin Expenses, Total

2,109.1

2,358.9

2,515.7

2,685.6

2,413.1

2,536.5

R&D Expenses

2,597.2

2,272.8

3,984.6

2,497.0

2,228.7

2,489.6

Amortization of Goodwill and Intangible Assets

381.2

274.0

255.1

252.0

246.3

219.4

Other Operating Expenses

185.0

241.6

232.9

7.2

-7.4

199.7

Other Operating Expenses, Total

5,272.5

5,147.3

6,988.3

5,441.8

4,880.7

5,445.2

Operating Income

6,364.1

7,275.2

4,651.1

3,430.2

3,014.4

2,062.1

Interest Expense, Total

-200.6

-187.4

-213.1

-250.4

-246.6

-230.2

Interest And Investment Income

112.5

120.0

42.0

11.0

89.3

302.6

Net Interest Expenses

-88.1

-67.4

-171.1

-239.4

-157.3

72.4

Income (Loss) On Equity Invest.

—

-79.4

5.3

34.9

2.6

—

Currency Exchange Gains (Loss)

-9.9

-7.0

-10.7

-22.4

-35.5

-27.3

Other Non Operating Income (Expenses)

-7.7

-44.4

7.8

1.5

-3.0

17.1

EBT, Excl. Unusual Items

6,258.4

7,077.0

4,482.4

3,204.8

2,821.2

2,124.3

Restructuring Charges

-12.0

-1.5

—

—

-131.1

-145.1

Merger & Related Restructuring Charges

—

-26.2

—

—

—

-29.6

Gain (Loss) On Sale Of Investments

119.5

204.7

685.7

-824.9

1,228.1

-399.4

Gain (Loss) On Sale Of Assets

—

-55.3

92.5

—

503.7

—

Asset Writedown

-366.1

-215.9

-209.7

-629.3

-119.6

-119.6

In Process R&D Expenses

-112.5

—

-75.0

-18.0

—

—

Legal Settlements

—

—

—

—

-917.0

-17.0

Other Unusual Items

12.3

63.7

76.9

47.5

209.1

195.4

EBT, Incl. Unusual Items

5,899.6

7,046.5

5,052.8

1,780.1

3,594.4

1,609.0

Income Tax Expense

1,425.6

1,158.0

992.3

52.5

632.8

146.9

Earnings From Continuing Operations

4,474.0

5,888.5

4,060.5

1,727.6

2,961.6

1,462.1

Minority Interest

-43.3

—

-59.9

-171.5

85.3

-0.3

Net Income

4,430.7

5,888.5

4,000.6

1,556.1

3,046.9

1,461.8

Net Income to Common Incl Extra Items

4,430.7

5,888.5

4,000.6

1,556.1

3,046.9

1,461.8

Net Income to Common Excl. Extra Items

4,430.7

5,888.5

4,000.6

1,556.1

3,046.9

1,461.8

Total Shares Outstanding

197.2

174.2

152.4

147.0

144.1

144.9

Weighted Avg. Shares Outstanding

204.9

187.1

160.9

149.1

145.3

144.5

Weighted Avg. Shares Outstanding Dil

205.3

187.4

161.3

149.6

146.0

145.5

EPS

21.6

31.5

24.9

10.4

21.0

10.1

EPS Diluted

21.6

31.4

24.8

10.4

20.9

10.1

EBITDA

7,014.6

7,739.9

5,108.3

3,917.9

3,532.8

2,536.6